BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 28, 2011
 |  BC Week In Review  |  Company News  |  Deals

Almirall, Kyorin deal

Almirall granted Kyorin Pharmaceutical exclusive rights in Japan to develop and commercialize chronic obstructive pulmonary disease (COPD) candidate aclidinium bromide. Almirall will receive an upfront payment and milestones totaling...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >